Advanced Filters
noise

Pneumonia Clinical Trials

A listing of Pneumonia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,326 clinical trials
S Stefan Habringer, MD

Secondary Central Nervous System Lymphoma Registry - Charité

The objective of the observation is to collect and document data on treatment strategies for secondary central nervous system lymphoma (SCNSL) in routine clinical practice, whether obtained in the context of clinical trials or outside of trials. In particular, the following questions will be specified: What therapeutic approaches are being …

years of age All Phase N/A
K Kai Hübel

A Registry Study on HIV-related Lymphoma

Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.

18 years of age All Phase N/A
P Pengpeng XU, MD, PhD

Cell Free DNA in Mature B-cell Lymphoma

The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.

18 years of age All Phase N/A
D Dr Aïssata BARRY, DR

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.

- 18 years of age All Phase N/A
G GI and Lymphoma Unit

CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study

A prospective imaging and translational tissue study in CNS lymphoma to enable further disease characterisation and the development of potential predictive and prognostic biomarkers.

18 years of age All Phase N/A
S Sam Springer, MSc

Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are: Is the new quantification method superior with respect to the method currently used in the clinic? Does the …

18 years of age All Phase N/A
D Dustin M. Silk

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

This study assesses neurocognitive outcomes after receiving radiation therapy to the brain (whole brain radiation therapy) in patients with blood cancers (hematologic malignancies). This may help researchers learn more about the effects of whole brain radiation therapy on memory and thinking in patients with blood cancer.

18 years of age All Phase N/A
D Dermatology CTU

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.

18 - 89 years of age All Phase N/A
E Elisa Lucchini, Dr.

Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

This is a observational, retrospective and prospective study designed to assess the potential correlations between MYC alterations, lymphoma mutational landscape and functional immune contextures in Diffuse Large B-cell Lymphoma or High-Grade B-cell Lymphoma

18 - 79 years of age All Phase N/A
H Hongmei Jing, Professor

Zanubrutinib in the Treatment of Recurrent Refractory Mantle Cell Lymphoma

80% of patients with mantle cell lymphoma (mantle cell lymphoma, MCL)were in the advanced tumor stage when they were first diagnosed. Zabutinib, as a new generation of BTK inhibitors, has better targeting and safety in clinical application. Previous studies have confirmed that zabutinib has good efficacy in treating relapsed refractory …

18 - 80 years of age All Phase N/A

Simplify language using AI